(Q39522907)

12 September 2017

Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction (English)

1 reference

12 September 2017

0 references

myocardial infarction

1 reference

2

1 reference

12 September 2017

Kontopoulos AG

1

1 reference

12 September 2017

Papageorgiou AA

series ordinal

3

1 reference

12 September 2017

Boudoulas H

series ordinal

4

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Cardiology

12 September 2017

1 reference

12 September 2017

84

1 reference

12 September 2017

10

1 reference

12 September 2017

1164-1169

1 reference

Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators.

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Circadian variation of sudden cardiac death reflects age-related variability in ventricular fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Circadian variation in sudden cardiac death: effects of age, sex, and initial cardiac rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

7 January 2021

Heart rate variability

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Circadian variation of heart rate variability in postinfarction patients with and without life-threatening ventricular tachyarrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Prognostic value of reduced heart rate variability after myocardial infarction: clinical evaluation of a new analysis method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Heart rate variability as a means of assessing prognosis after acute myocardial infarction. A 3-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Power spectral analysis of cardiovascular variability in patients at risk for sudden cardiac death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Parasympathetic activity is a major modulator of the circadian variability of heart rate in healthy subjects and in patients with coronary artery disease or diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Chronobiology of acute myocardial infarction: cardiac arrhythmia suppression trial (CAST) experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Fractal clustering of ventricular ectopy correlates with sympathetic tone preceding ectopic beats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Effects of cardiac rehabilitation and beta-blocker therapy on heart rate variability after first acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Influence of captopril on the arterial baroreceptor reflex in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

ACE inhibition improves vagal reactivity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Effect of quinapril on blood pressure and heart rate in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Hypersensitivity to Adrenergic Stimulation after Propranolol Withdrawal in Normal Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900528-7

10.1016/S0002-9149(99)00528-7

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference